sellmefear
← all entries

OUTLETS DISAGREEWednesday 12 August 2026

Outlets disagree: Timeline for implementation of splitting the MMR vaccine

reuters.com; marketscreener.com

As published

4 pages captured at the time, in each outlet's own typography. Open one to read the copy held outside the publisher's control.

What this entry found

  • ONE SOURCE, MANY MASTHEADS

    4 outlets carried this. They resolve to 3 independent sources.

    A reader sampling these outlets received 3 accounts, not 4.

  • ONLY ONE OUTLET HAD THIS

    cnbc.com carried 6 details no other outlet reported.

    • Trump said without evidence that the combined MMR vaccine could be 'quite lethal'
    • The U.S. has logged its highest number of measles cases in decades in the current year
    • There has been a decrease in the share of parents willing to use the MMR shot, contributing to recent resurgence in measles cases
    • Splitting the vaccine would result in more delayed or missed vaccinations among children due to multiple doctor's visits required
    • Experts called Trump's claim that the vaccine could be 'quite lethal' 'completely false'
    • Experts say splitting the MMR vaccine lacks scientific basis

A finding about the sourcing

4 mastheads carried this. They resolve to 3 independent sources.

A wire service is among the sources (reuters.com), which is the ordinary route for identical text.

Searched: 4,362 headlines gathered from 15 standing searches across 14 country editions. No further outlet in that pull reported this independently.

Absence here means absence from this record, not from the press. The pull covers a 24-hour window and the feeds listed on the method page; a story can be well covered somewhere this pipeline does not look.

This entry reports where the text came from. It does not assert that the reporting is wrong.

4outlets3independent
What happened, for context

President Trump signed an executive order calling for the MMR vaccine to be split into three separate shots. Medical experts stated the proposal lacks scientific basis, claims about vaccine safety were disputed, and implementation would face significant logistical challenges and could reduce vaccination rates.

1 of 4 articles were readable. Headline only, no body text retrieved, for: axios.com, marketscreener.com, reuters.com. Nothing below is drawn from those outlets beyond their headline.

Who reported it

    • reuters.comWIRE
    • marketscreener.comUNCLASSIFIED
    identical copy
  • axios.comINDEP
  • cnbc.comUNCLASSIFIED

References

Reported unevenly

  • Timeline for implementation of splitting the MMR vaccinestated by reuters.com, marketscreener.com · absent from axios.com, cnbc.com